You got the call. Your biopsy came back, and the skin cancer doesn’t appear to reach the edge of the removed tissue. Your report says something like closely approaches margin or narrowly free. You exhale. Good news, right?
Maybe. But your provider is still recommending a re-excision — and understandably, that can feel confusing, even frustrating. If the tumor isn’t at the edge, why go back in?
It’s a fair question, and the answer lives somewhere between geometry, biology, and the honest limitations of what a microscope can show us from a single slice of tissue.
The Bread Loaf Problem
When a dermatopathologist evaluates an excision, the tissue isn’t examined all at once. The specimen — often an ellipse of skin — is sectioned serially, like slicing a loaf of bread. Each slice is roughly the thickness of a nickel. From each of those slices, one representative slide is prepared and read under the microscope.
That’s thorough. But it’s not exhaustive.
Here’s why that matters: a basal cell carcinoma isn’t a perfect sphere with smooth, predictable edges. It’s irregular. Jagged. It can have satellite foci — small islands of tumor that jump away from the main mass. So even when the primary tumor bulk looks clear of the inked margin on the slide being reviewed, a small cluster of cells extending toward the edge could exist in the tissue between the sections that were sampled.
Think of it this way: if the tumor has an irregular arm reaching toward the margin, and that arm happens to fall between two bread slices rather than on one of them, it won’t show up on the slides — but it’s still there.
Skip Patterns Add Another Layer
Beyond the sampling issue, some tumors exhibit what’s called a skip pattern — meaning tumor cells don’t grow as one continuous mass. They can appear, disappear, and reappear across the tissue. A margin can look clear at one level and not be clear a fraction of a millimeter deeper.
This isn’t a flaw in the pathology process. It’s the biological reality of how certain tumors behave, and it’s exactly why the recommendation to re-excise exists.
What “Narrowly Free” Is Really Telling You
When a pathologist reports that a tumor narrowly approaches or is narrowly free of a margin, they’re being precise — and honest. It means: based on what we can see in the sections we examined, tumor cells are not on the inked edge. But given the thickness of tissue blocks, the irregular nature of tumor growth, and the possibility of skip patterns, there is meaningful risk that cells remain beyond what the slides can confirm.
That’s not a reason to panic. It is a reason to go back and get clean margins.
Re-Excision Is the Cleaner Path Forward
Skin cancers like basal cell carcinoma are very treatable — especially when caught and cleared early. Left behind, even a small residual focus can continue to grow, become locally destructive, and require far more intervention down the road.
Re-excision, while an extra step, is the most straightforward way to confirm clearance and protect against recurrence. Your provider isn’t being overly cautious — they’re being thorough in exactly the way you’d want them to be.
The Bottom Line
“Narrowly free” is good information. It’s just not the whole picture. The tissue block has depth that a single slide can’t fully capture, and tumor biology doesn’t always cooperate with clean lines. Re-excision closes that gap — and gives both you and your care team confidence that the job is done.
Have questions about a biopsy result or a re-excision recommendation? The team at Stratum Dx is here. Visit us at stratumdx.com.